Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Inwido’s Business Unit Elitfönster invests in new production technology – for increased productivity

Elitfönster is making its largest individual investment ever to increase productivity in its manufacturing of windows. With the investment in a new, highly automated planing machine at the Vetlanda factory, Elitfönster will streamline and modernize its production, starting in the first quarter of 2020. The investment amounts to SEK 55 million.The Vetlanda factory produces windows for customers in Sweden and for export. To control production more efficiently and in synchronization with customers’ precise needs, Inwido and Elitfönster are investing for the future.   “The investment secures

Episurf Medical reaches milestone of 600 implants

Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached another milestone by the planning of the 600th surgery with the Episealer® implant in the coming weeks. The company recently communicated that the patient groups who have had the implant for more than 2 and 3 years had grown, and today the company announces further growth in the overall patient population.    “This is yet another important milestone, and I am very pleased with the good results that we can see, in addition to the growing volumes", says Prof. Leif Ryd, Senior Medical Advisor to Episurf Medical.

CFO has decided to relocate to the UK and will leave Nordea in 2020

Nordea Bank Abp – Changes board/management/auditors Group CFO and Head of Group Finance and Treasury Christopher Rees has decided to relocate back to the UK with his family to pursue new opportunities and will leave Nordea in 2020. A search for a successor has been initiated. Christopher Rees will continue in his role and as a member of Group Executive Management until a successor has been appointed and responsibilities orderly transferred. Christopher Rees joined Nordea in 2015 in Wholesale Banking where he held several roles including Chief Operating Officer, Head of Markets and

DG500 commissioning and testing update

Minesto’s DG500 kite system was installed at the company’s Holyhead Deep site offshore North Wales in mid-August using an upgraded launch and recovery system. Since then Minesto has made significant progress in commissioning the autonomous control and power generation systems.“The major changes to the kite system this year are that we now operating with a shorter tether and over winter we enhanced the power take-off system to make it simpler and hence more reliable. So far during the commissioning programme we are very pleased with the operation of the improved power take-off system and the

Scania Growth Capital invests in Software as a Service provider and consultancy firm AKOA

Scania’s corporate venture capital fund announces an investment in AKOA, a fast-growing company in business process automation. The investment will enable AKOA to further accelerate its growth in new markets, as well as to strengthen its organisation and offering. This marks the fifth investment by Scania Growth Capital.As modern organisations become increasingly reliant on systems and software to support and enable their business in a more digital world, the need for automation and digital transformation solutions is increasing. A growing number of tasks and processes have moved from

We are a team of generalist-specialists

There are many different ways to organize a company and its departments. Every way has its advantages and disadvantages, but it is important to understand what works best for the business.A Society has organized its processes based on the idea that all our coworkers, regardless of which department they belong to, can influence and enhance customer experience. In our first article we talked about why our financial department has received an extra title ”Service Management”. In this article, which is number 2 in our series 

FlexQube receives an order worth $400 000 from Mann+Hummel

FlexQube has received an order for material handling trolleys and Liftrunner B-frames from Mann+Hummel Filtration Technology US LLC.The total order value is $400 000 and the order will be delivered in the first quarter of 2020 to the Mann+Hummel plant in Gastonia, NC. “This is the first larger order we receive after signing the distributor agreement with STILL GmbH in March 2019, concerning the Liftrunner product line. There is potential for additional orders for others Mann+Hummel plants going forward, especially in USA and Mexico where we can offer the FlexQube carts together with the

Epiroc AB’s Nomination Committee for the Annual General Meeting 2020

Stockholm, Sweden: According to the Instruction for the Nomination Committee adopted by the Annual General Meeting of Epiroc AB, the Nomination Committee should consist of representatives for the four shareholders, directly registered or ownership grouped, controlling the largest number of votes in Epiroc AB that desire to appoint a member. In addition thereto, the Chairman of the Board of Directors shall be a member.The following persons will form the Nomination Committee for the Annual General Meeting 2020. Petra Hedengran - Investor AB (Chair)Ramsay Brufer – Alecta Jan Andersson –

NENT Group presents ‘Thicker than Water’ as next original series

· New season of hit Swedish-Finnish drama to be shown exclusively on NENT Group’s Viaplay streaming service  · ‘Thicker than Water’ produced by NENT Studios’ Nice Drama · NENT Group to premiere at least 20 original productions every year ‘Thicker than Water’ is the next original production from Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company. The first two seasons of the Swedish-Finnish drama series, which were co-produced by local public service broadcasters SVT and YLE, attracted large audiences and critical acclaim across the Nordic region.

Klaria initiates large-scale production of KL-00119 oral film (sumatriptan) for its clinical registration trial

Today, Klaria announces that large-scale production of the company’s lead migraine product KL-00119 oral film (sumatriptan) has been initiated at its manufacturing partner Adhex Pharma’s site in Dijon, France. Initially, KL-00119 is produced for the pivotal clinical trial scheduled for 2020 prior to registration and marketing of the product.The clinical trial is currently designed to last approximately 8-10 weeks. It will be followed by market registration submissions based on the full data file to regulatory authorities covering all important markets, including the EU and the US.

Leaf spring in innovative life-saving bicycle airbag

In the process of developing the third generation of the groundbreaking airbag helmet Hövding, the company's product developers contacted Lesjöfors. Together, they created a customized wire form for the activation mechanism and a spring clip that hold the gas generator in place.Hövding is a pioneering airbag helmet for cyclists, a Swedish innovation from two young industrial designers in Malmö. In the event of an accident, the airbag is triggered from a collar in just 0.1 seconds. Tests show that the airbag offers cyclists superior protection against head injuries, Hövding’s airbag

Ranplan appoints Jon Ullmark as Chief Strategy Officer

Ranplan Group AB has recruited Jon Ullmark, a specialist in the field of IoT and Automation, for the newly created position as Chief Strategy Officer and member of the Senior Management Team.Effective 1 September 2019, Jon joins Ranplan from Hoylu where he was Deputy CEO and General Manager for EMEA. Prior thereto, Jon has held leadership roles within Semcon (Area Manager), C Security Systems (CEO), and Pilotfish Marine (Acting CEO). "A recognised expert tasked with the commercialisation of Artificial Intelligence, Machine Learning and Automation, Jon comes on board at a defining moment

Conclusion of EAB Group Plc’s co-operation negotiations

EAB Group Plc, Inside Information, Stock Exchange Release, 18 September 2019, 9:10 a.m. (EET) Conclusion of EAB Group Plc’s co-operation negotiations EAB Group Plc (“Company”) announced on 28 August 2019 that it will start planning an efficiency program and the co-operation negotiations related to the program in all EAB Group companies (“Group”). The Group has concluded the co-operation-negotiations on 17 September 2019. After the negotiations, the Group will lay off 9 persons, of which an employment contract for new tasks can be offered for two persons. The purpose of the co-

Updated company presentation and invitation to lunch presentations in Oslo, Stavanger and Trondheim

Nordic Mining ASA has updated its company presentation for investor meetings in relation to the rights issue resolved by the general assembly on 13 September. The presentation material is attached hereto.In connection with the rights issue, Nordic Mining would like to invite to the following lunch presentations: ·  24 September at 10:00 CEST at SpareBank 1 Markets | Olav Vs Gate 5, Oslo ·  25 September at 12:30 CEST at SpareBank 1 Markets | Bjergested Terasse 1, Stavanger ·  27 September at 11:00 at SpareBank 1 Markets | Søndre Gate 4, Trondheim Kindly register at

DiviTum® Included in New U.S. Cancer Study

Biovica and the SWOG Cancer Research Network have entered into an agreement to study the clinical benefit of DiviTum® using patient blood samples from SWOG 0226, a clinical trial that showed that women with metastatic hormone receptor-positive breast cancer live longer when they receive a combination of two anti-estrogen drugs.Under the agreement, the DiviTum® blood assay will be used to analyze blood samples taken from participants in S0226, which between 2004 and 2009 enrolled 707 postmenopausal women with metastatic breast cancer at 73 hospitals, clinics, and cancer centers across the

Biovica invites to telephone conference/audiocast

Uppsala, Sweden, September 18, 2019. Biovica invites investors, analysts and the media to a presentation where Anders Rylander, CEO, and Mattias Bergqvist, Clinical Development Director, comments on today’s announcement. The presentation will be held on 19 September 2019 at 10:00 CET and can be followed via telephone conference or audiocast.The presentation will be held in English and will be followed by a questions and answers session. Questions can be asked via the telephone conference or in written form via the audiocast. No pre-registration is needed. Participant dial in number DK:

Proact helps Telia Company develop the foundations for future digital transformation

Using its agnostic position as an independent data centre and cloud services provider, Proact is helping Telia Company realise its vision for growth and future innovation with true-best fit technologies. By introducing infrastructure solutions across six data centres, and by leveraging Proact’s support and consultancy skills, Telia Company now has the right building blocks in place to support its workloads.Telia Company, the leading telecom service provider in the Nordics, treats transitioning and upgrading its IT infrastructure like an evolutionary process. First Telia Company decides the

XPS™ sold to China

XVIVO Perfusion has sold an XPS™ to the second largest lung transplant clinic in China. The purpose is to start EVLP (Ex Vivo Lung Perfusion)-research at the CHINA-JAPAN FRIENDSHIP HOSPITAL in Beijing.China is currently the fastest growing lung transplant market in the world, with a 35 % increase in lung transplants in 2018 (403 lung transplants performed). Due to the increased need for lung transplantation the number of clinics authorized to perform lung transplants has increased from 20 clinics in 2016 to 37 clinics in 2018. The lung transplant program lead by Professor JINGYU CHEN

Hansa Biopharma: Positive results presented at ESOT; imlifidase enabled  transplantation in 46 sensitized patients

Lena Winstedt, PhD, Head of Science at Hansa Biopharma, presented positive results from a pooled analysis of Phase 2 trials with imlifidase for desensitization in sensitized kidney transplant patients.Lund, Sweden September 18, 2019. Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced that positive imlifidase data were highlighted in a presentation at the 19th Congress of the European Society for Organ Transplantation (ESOT) 2019 in Copenhagen, Denmark. Lena Winstedt, PhD, Head of Science at Hansa Biopharma, presented “Imlifidase

Neste's Shareholders' Nomination Board appointed

Neste Corporation, Stock Exchange Release, 18 September 2019 at 9 am. (EET) The following members have been appointed to Neste's Shareholders' Nomination Board: The Chair, Director General Kimmo Viertola of the Ownership Steering Department in the Prime Minister’s Office of Finland; Deputy CEO, Investments Reima Rytsölä of Varma Mutual Pension Insurance Company; President and CEO Jouko Pölönen of Ilmarinen Mutual Pension Insurance Company and Matti Kähkönen, the Chair of Neste's Board of Directors. In line with a decision taken by the Annual General Meeting held on 4 April 2013, the

Management changes at Handelsbanken

Jan Larsson has been appointed Chief Communications Officer. He is currently CEO of Yrkesakademin AB. He will assume his new position by March 2020, at the latest. In his new position, Jan Larsson will be a member of Handelsbanken’s Executive Management. Martin Noréus has been appointed Chief Compliance Officer. He is currently Deputy Director General of the Swedish Financial Supervisory Authority, Finansinspektionen. Martin Noréus will assume his new position by March 2020, at the latest. For further information, please contact:Carina Åkerström, President and Group Chief Executive,

YIT reviews its strategy: Sustainable urban development to drive performance through cycles

YIT Corporation                  Stock exchange release                          September 18, 2019 at 09:00 a.m.YIT reviews its strategy: Sustainable urban development to drive performance through cycles YIT’s Board of Directors has reviewed the company’s strategy for 2020–2022. The target of the reviewed strategy continues to be to improve profitability and to maintain financial stability. The core of YIT’s business model and its growth engine is sustainable urban development, YIT’s unique ability to generate self-developed and other projects that include design responsibilities.

AstraZeneca amends collaboration with Ironwood for Linzess in China

18 September 2019 07:00 BST     AstraZeneca amends collaboration with Ironwood for Linzess in China     New agreement gives AstraZeneca full responsibility for developing, manufacturing and commercialising Linzess in China    AstraZeneca has amended its collaboration agreement  with Ironwood Pharmaceuticals, Inc. (Ironwood) in China mainland, China Hong Kong and China Macau for Linzess* (linaclotide), a first-in-class new treatment for

Therese Cedercreutz elected as Chairman of the Board for EAB Group Plc

EAB Group Plc, Stock Exchange Release, 18 September 2019, 9:00 a.m. (EET) Therese Cedercreutz elected as Chairman of the Board for EAB Group Plc The Board of Directors of EAB Group Plc (EAB, Company) has in its meeting today 18 September 2019 elected Therese Cedercreutz (born 1969) as Chairman of the Board. Cedercreutz has been a member of the Board since spring 2019. She has more than 25 years of international experience in business development, strategy, sales and marketing. Cedercreutz has assisted several successful Finnish public companies in their strategy work and business

There are no items matching the current filter
There are no more items matching the current filter
Back to top